Last line of defence crumbling: WHO report on global antimicrobial resistance
This article was originally published in Scrip
Drug resistance to carbapenem antibiotics, which are used as a last-resort for treating hospital acquired bacterial infections caused by Klebsiella pneumoniae, such as pneumonia, bloodstream infections and infections in newborns, has spread to all regions of the world. This is the key finding by the World Health Organization (WHO) in its first ever report on antimicrobial resistance globally.
You may also be interested in...
The Scrip 100 universe gathers FY 2019 financial performance data and compares the activities of the Top 100 biopharma businesses, ranked by pharma sales. Here In Vivo breaks out the Top 10 in the league table. Which big pharma holds the top spot this year?
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.